Cargando…
Overexpression of the Toll-Like Receptor (TLR) Signaling Adaptor MYD88, but Lack of Genetic Mutation, in Myelodysplastic Syndromes
MYD88 is a key mediator of Toll-like receptor innate immunity signaling. Oncogenically active MYD88 mutations have recently been reported in lymphoid malignancies, but has not been described in MDS. To characterize MYD88 in MDS, we sequenced the coding region of the MYD88 gene in 40 MDS patients. No...
Autores principales: | Dimicoli, Sophie, Wei, Yue, Bueso-Ramos, Carlos, Yang, Hui, DiNardo, Courtney, Jia, Yu, Zheng, Hong, Fang, Zhihong, Nguyen, Martin, Pierce, Sherry, Chen, Rui, Wang, Hui, Wu, Chenghua, Garcia-Manero, Guillermo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744562/ https://www.ncbi.nlm.nih.gov/pubmed/23976989 http://dx.doi.org/10.1371/journal.pone.0071120 |
Ejemplares similares
-
DOCK8 functions as an adaptor that links Toll-like receptor–MyD88 signaling to B cell activation
por: Jabara, Haifa H., et al.
Publicado: (2012) -
Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents
por: Yang, Hui, et al.
Publicado: (2013) -
TLR signaling adaptor protein MyD88 in primary sensory neurons contributes to persistent inflammatory and neuropathic pain and neuroinflammation
por: Liu, Xing-Jun, et al.
Publicado: (2016) -
Lack of Associations between TLR9 and MYD88 Gene Polymorphisms and Risk of Chronic Lymphocytic Leukemia
por: Ali, Yasser B.M, et al.
Publicado: (2017) -
Toll-Like Receptors and Cancer: MYD88 Mutation and Inflammation
por: Wang, James Q., et al.
Publicado: (2014)